13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-01-18, with 13 holding rows worth $70,966,000.
- Accession
- 0001381843-22-000002
- Filer
- CIK 1381843
- Filed
- 2022-01-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 13 entries on the cover page, a total value of $70,966,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $70,966,000 with VALUE read as thousands by filing date, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 730,000 | $8,512,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 34,000 | $8,451,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 195,000 | $8,315,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 48,000 | $6,499,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 125,000 | $6,436,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 48,000 | $6,379,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 100,000 | $6,235,000 | thousands by filing date | |
| UTAH MEDICAL PRODUCTS INC | 917488108 | COMMON STOCK | 40,000 | $4,000,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 830,000 | $3,860,000 | thousands by filing date | |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 2,000,000 | $3,240,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 195,000 | $3,169,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 183,000 | $2,981,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,090,000 | $2,889,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001381843-22-000002 | this filing | 2022-01-18 | acceptance time not in the bulk data set |